DNAJC27 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.31189511978869E-11 |
Normal-vs-Stage2 |
1.97603999999574E-05 |
Normal-vs-Stage3 |
<1E-12 |
Normal-vs-Stage4 |
<1E-12 |
Stage1-vs-Stage2 |
9.551600E-01 |
Stage1-vs-Stage3 |
4.01720000000605E-05 |
Stage1-vs-Stage4 |
5.52740000436813E-08 |
Stage2-vs-Stage3 |
1.615670E-02 |
Stage2-vs-Stage4 |
2.178800E-03 |
Stage3-vs-Stage4 |
2.571400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62481139653892E-12 |
Normal-vs-AfricanAmerican |
8.44410000033768E-07 |
Normal-vs-Asian |
2.174000E-02 |
Caucasian-vs-AfricanAmerican |
1.056800E-01 |
Caucasian-vs-Asian |
4.003800E-01 |
AfricanAmerican-vs-Asian |
8.633400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
2.90830026727917E-10 |
Male-vs-Female |
1.463630E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.67430000156344E-08 |
Normal-vs-Age(41-60Yrs) |
3.2218672174622E-12 |
Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
Normal-vs-Age(81-100Yrs) |
1.21880000003571E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.312400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.154400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.091600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.782300E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.116800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.829600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.041200E-01 |
Normal-vs-Grade 2 |
2.4134000353726E-09 |
Normal-vs-Grade 3 |
1.62436730732907E-12 |
Normal-vs-Grade 4 |
<1E-12 |
Grade 1-vs-Grade 2 |
1.282470E-02 |
Grade 1-vs-Grade 3 |
4.164100E-03 |
Grade 1-vs-Grade 4 |
5.169800E-04 |
Grade 2-vs-Grade 3 |
4.20950000001863E-06 |
Grade 2-vs-Grade 4 |
3.19809734250498E-11 |
Grade 3-vs-Grade 4 |
9.838700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.09389999678211E-08 |
Normal-vs-ccB subtype |
1.62436730732907E-12 |
ccA subtype-vs-ccB subtype |
6.47260001152006E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.71129777015722E-12 |
Normal-vs-N1 |
1.44209999497491E-09 |
N0-vs-N1 |
1.876760E-03 |
|
|